NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1.

Cell Death and Differentiation
A CraxtonGerald M Cohen

Abstract

Ubiquitin (Ub)-mediated proteasome-dependent proteolysis is critical in regulating multiple biological processes including apoptosis. We show that the unstructured BH3-only protein, NOXA, is degraded by an Ub-independent mechanism requiring 19S regulatory particle (RP) subunits of the 26S proteasome, highlighting the possibility that other unstructured proteins reported to be degraded by 20S proteasomes in vitro may be bona fide 26S proteasome substrates in vivo. A lysine-less NOXA (NOXA-LL) mutant, which is not ubiquitinated, is degraded at a similar rate to wild-type NOXA. Myeloid cell leukemia 1, but not other anti-apoptotic BCL-2 family proteins, stabilizes NOXA by interaction with the NOXA BH3 domain. Depletion of 19S RP subunits, but not alternate proteasome activator REG subunits, increases NOXA half-life in vivo. A NOXA-LL mutant, which is not ubiquitinated, also requires an intact 26S proteasome for degradation. Depletion of the 19S non-ATPase subunit, PSMD1 induces NOXA-dependent apoptosis. Thus, disruption of 26S proteasome function by various mechanisms triggers the rapid accumulation of NOXA and subsequent cell death strongly implicating NOXA as a sensor of 26S proteasome integrity.

References

Aug 1, 1995·Archives of Biochemistry and Biophysics·T Shibatani, W F Ward
Oct 6, 1998·Annual Review of Biochemistry·A Hershko, A Ciechanover
Dec 12, 2001·The Journal of Biological Chemistry·Cezary Wójcik, George N DeMartino
Dec 31, 2003·The Journal of Experimental Medicine·Jee-Youn KimJae-Hoon Park
Apr 2, 2004·Trends in Cell Biology·Aaron Ciechanover, Ronen Ben-Saadon
Jul 19, 2005·Cancer Research·Jian-Zhong QinBrian J Nickoloff
Mar 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Peter E CzabotarPeter M Colman
Nov 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mikhail A NikiforovMaria S Soengas
Dec 22, 2007·Nature Reviews. Molecular Cell Biology·Richard J Youle, Andreas Strasser
Jan 19, 2008·Nature Reviews. Cancer·Anthony G Letai
Jun 19, 2008·Biochimica Et Biophysica Acta·Isabelle Jariel-EncontreMarc Piechaczyk
Oct 22, 2008·Expert Review of Anticancer Therapy·Thomas E Hutson
Jul 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Nitzan ShabekAaron Ciechanover
Oct 21, 2009·Nature Chemical Biology·Peter TsvetkovYosef Shaul
Oct 21, 2009·Nature Chemical Biology·Erin K SchraderAndreas Matouschek
Dec 22, 2009·Nature·Martin SchwickartVishva M Dixit
Apr 14, 2010·Molecular and Cellular Biology·Daniel P StewartJoseph T Opferman
May 15, 2010·Molecular & Cellular Proteomics : MCP·Friedrich FörsterWolfgang Baumeister
May 21, 2010·The Journal of Clinical Investigation·Zhifu XiangMichael H Tomasson
Jun 24, 2011·Nature Reviews. Molecular Cell Biology·Domagoj VucicIngrid E Wertz
Sep 13, 2011·Biochemical and Biophysical Research Communications·Patricia Gomez-BougieMartine Amiot

❮ Previous
Next ❯

Citations

Jun 5, 2013·Apoptosis : an International Journal on Programmed Cell Death·Arnim WeberGeorg Häcker
Aug 20, 2015·EBioMedicine·David S PitcherMaurits F Kleijnen
Nov 7, 2015·Trends in Biochemical Sciences·Abdel AouacheriaJ Marie Hardwick
Mar 26, 2015·Frontiers in Genetics·Kerstin BrinkmannHamid Kashkar
Sep 5, 2014·Cellular and Molecular Neurobiology·Ivana PilchovaPeter Racay
Jul 7, 2011·PLoS Pathogens·Mireille LaforgeJérôme Estaquier
Mar 20, 2014·PloS One·Matthew C ExlineAnasuya Sarkar
Jan 12, 2013·PloS One·Soratree CharoenthongtrakulEdward W Harhaj
Jul 4, 2017·Expert Opinion on Therapeutic Targets·Jeroen E GuikemaEric Eldering
May 3, 2018·Medicinal Research Reviews·Ribhav MishraAmit Mishra
Sep 9, 2017·Cell Death and Differentiation·Hilla SolomonMichal Sharon
Jul 9, 2013·Cell Death and Differentiation·S VaradarajanG M Cohen
Feb 21, 2018·EMBO Reports·Manuel HaschkaAndreas Villunger
Apr 7, 2020·International Journal of Cancer. Journal International Du Cancer·Hsin-Yi TsengStuart Gallagher
Nov 10, 2013·Cancers·Alessandro NatoniCorrado Santocanale
May 9, 2014·The Journal of Biological Chemistry·Xiaming PangXu Luo
Dec 2, 2014·Oncotarget·Alexey AntonovIvano Amelio
Jan 1, 2014·Molecular & Cellular Oncology·Marie-Christine AlbertHamid Kashkar
Mar 25, 2014·Oncotarget·Ivana CelardoGerry Melino
Aug 9, 2018·Cellular Oncology (Dordrecht)·Lisett ContrerasRenato J Aguilera
Feb 13, 2019·The Journal of Cell Biology·Ryan L HansonEric Batchelor
Sep 12, 2020·Cell Death & Disease·Marie-Christine AlbertHamid Kashkar
Oct 7, 2020·Cells·Yohannes Afework MebratuYohannes Tesfaigzi
Sep 4, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Weihua ZhouYi Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.